Introduction
============

While most regulatory agencies heavily rely on toxicological data, the results of epidemiology studies are becoming more and more important in this area. For this reason and for public health purposes, in general, a critical review of the epidemiologic literature on crop protection products is of increasing value. The herbicide, 2,4-dichlorophenoxyacetic acid (2,4-D), is an example of a pesticide for which the epidemiology data are continually reviewed and debated. Recently re-registered for use by [@b47], and the [@b103], 2,4-D is currently being re-evaluated by the European Union. A past review by [@b32] emphasized the inconsistent nature of the studies up to 2000 that precluded drawing any conclusion on carcinogenicity in humans. Reviewing the literature through 2001, [@b33] observed more strongly that the epidemiology data "provide scant evidence that supports a conclusion that exposure to 2,4-D is associated with STS \[soft tissue sarcoma\], NHL \[non-Hodgkin lymphoma\] or HD \[Hodgkin\'s Disease\]." Since no qualitative review of the 2,4-D epidemiology literature since 2001 has been published we present an update in this paper.

The herbicide, 2,4-D, has been registered for use since the 1940s. As a selective herbicide, 2,4-D is used to control broadleaf weeds in a variety of settings from crops, rights-of-way, lawns, forests to aquatic settings. In aerobic environments, 2,4-D degrades rapidly from 2 to 13 days ([@b110]). In humans, 2,4-D is excreted unmetabolized in urine with a half-life of 10 to 33 hours, an average of 17.7 hours ([@b20]; [@b87]). 2,4-D is cleared into urine of both animals and humans by a saturable organic anion transporter, OAT-1; toxicity of 2,4-D in rodents is typically limited to dose levels that saturate renal clearance (\>50 mg/kg/day). Toxicity observed in rodents at doses above renal saturation is generally not regarded as relevant to human health risk ([@b99]; [@b103]). Chronic toxicity of 2,4-D has been tested in laboratory animals at a wide range of dose levels ([@b33]; [@b103]). Studies in both rats and mice have shown no carcinogenic effect of 2,4-D and the US EPA classifes 2,4-D as a Group D chemical (not classifable as to human carcino-genicity). In two-generation reproduction studies there were no effects seen on fertility indices at doses up to and including 72 mg/kg/day. Reduced bodyweight gain has been seen at the higher doses (generally above the level at which renal excretion is saturated), with reduced food intake usually seen in parallel. Experimental in vitro and in vivo animal studies show no genotoxic potential for 2,4-D. Neurotoxicity studies showed aberrations in locomotion and open feld behavior at high doses saturating renal clearance but no histopathological findings in neural tissues. The neurotoxic signs were reversible and were at doses that exceeded general toxicity. As one of the most widely used herbicides in the world, 2,4-D continues to be one of the most studied pesticides, both in animals and in humans.

The purpose of this review is to provide a qualitative review of the human biomonitoring and epidemiology data since the summaries by [@b33] and [@b79]. The biomonitoring data on urine samples include publications since 1991, as they provide the most reliable information on human exposure. To our knowledge these data have not yet been comprehensively reviewed. Some exposure studies were conducted in the 1980s on commercial applicators to turf, forestry and crops ([@b63]; [@b64]; [@b112]). These studies will not be included since technical changes, specifcally improvements in analytical methods, have made these early studies less comparable to recent ones.

Methods
=======

Scope
-----

In 1986, the International Agency for Cancer Research (IARC) classified the chlorophenoxy herbicides as a Group 2B (possible) carcinogen ([@b58]). Tis monograph evaluated the group, which in addition to 2,4-D, includes other phenoxies such as MCPA and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) and related impurities of polychlorinated dioxins. Notably, IARC has not identified 2,4-D, *per se*, as a possible carcinogen. IARC sponsored an occupational cohort mortality study of 21,863 workers across 12 countries exposed to phenoxy herbicides. In their 1997 report, Kogevinas and colleagues stratifed the workers by those exposed to the contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and other chlorinated dioxins and workers unexposed to dioxins ([@b62]). These investigators noted that the dioxin contaminants have similar mechanisms of action and toxicities whereas the herbicides such as 2,4-D were not known to contain TCDD. In their review, [@b33] also designated cohorts with co-exposure to TCDD. The current review of human epidemiology and 2,4-D will use a similar approach. Where possible, results specific to 2,4-D will be presented and reviewed.

Interpretation
--------------

Tere are many approaches to compiling and reviewing a body of literature. The criteria or guidelines as proposed by Bradford Hill provide useful components to assess data. [@b95] proposed a quantitative approach to empirically consider the Hill criteria. They tested their approach using the agents classified as Class 1 or 2A carcinogens by the IARC and observed that in addition to the experimental evidence, the criteria of strength of association and consistency had the greatest weight. In the current review, we did not evaluate the animal or experimental data. Summaries are available from government regulatory agencies such as the US EPA and Health Canada ([@b103]; [@b47]). A strong association was considered to be a risk estimate or odds ratio greater than 2. We looked for consistency or replication of statistically significant results both within the same study and in independent studies. For example, results were considered to be internally inconsistent if exploratory analyses of all subjects were statistically signifcantly (*p* \< 0.05 or the upper and lower bound of the confidence limits excluded the null value) but analyses by dose level were not statistically significant. We looked for replication of statistically significant results of specific outcomes to be reported in more than one study to meet the guideline for external consistency.

Biomonitoring data were also considered to be informative. Limited data on exposure are generally considered to be the most critical component of epidemiology studies on pesticide exposure and potential health outcomes. Good quality biomonitoring data can significantly strengthen this shortcoming and can even provide a reliable metric for internal exposure. The biomonitoring data also provide an excellent opportunity to put the exposure to 2,4-D of the various human populations into its proper perspective. Therefore we have included a specific review of the available biomonitoring data on 2,4-D. These data were organized by opportunity for exposure (general population, bystander and occupational) to be in line with populations that are included in epidemiology studies and this approach is similar to that taken by regulators and risk assessors.

Search strategy
---------------

As part of a larger project to report the toxicology of 2,4-D, a systematic literature search using the terms "2,4-dichlorophenoxyacetic acid" and the chemical abstract service registration number, "94-75-7" was conducted on the databases BIOSYS, Pascal, Agricola, Chemical Safety News base, ELSEVIER, and CA SEARCH during the years 2000 to 5 January 2012. Another search contained more search terms that included "epidemiology," "human," "occupation," "workers," "women," "men," and "farmers." More than 12,000 references were identified. The abstracts were manually screened by topic and relevance. The studies relevant to human, epidemiology and biomonitoring were selected for this review. Although English language was not a criterion there were no relevant studies identified that needed translation into English. In addition, papers were reviewed when cited as part of other studies and publications.

Inclusion and exclusion
-----------------------

Studies that evaluated human health effects following exposure to herbicides in general were not considered. There are many chemicals used to control vegetation. The US EPA reported that in 2001, 2,4-D use in the United States was ranked third to herbicides glyphosate and atrazine ([@b104]). A survey for more than 35,000 pesticides applicators as part of the Agricultural Health Study observed that pesticides use varies by residence and commodity ([@b1]). Without further information from selected studies, we concluded that we would not attribute to 2,4-D a reported association of "herbicides" and a health effect. For example, we excluded the cancer mortality and illness and injury studies of herbicide applicators ([@b109]; [@b94]) for this reason. We excluded other studies for which the results were not specific to 2,4-D because they implied exposure from residence ([@b88]) or occupation ([@b34], [@b35], [@b36]; [@b38]; [@b115]; [@b70]; [@b86]).

Included were results for phenoxy herbicides and 2,4-D. In publications that reported analyses for all pesticides combined as well as individual exposures, only the results specifically addressing 2,4-D were reviewed.

Review of urinary biomonitoring
===============================

General population
------------------

The largest general population studies of 2,4-D urinary levels in children and adults are those conducted by the US Centers for Disease Control and Prevention [@b20] and [@b48]. With 2412 and 5480 subjects, respectively, both studies were designed to be representative of the national population ([Table 1](#tbl1){ref-type="table"}). Neither study detected 2,4-D at the 50th percentile (less than 1 parts per billion, ppb). These findings are similar to an earlier study by CDC ([@b49]). The US EPA\'s study of children and adults in North Carolina and Ohio ([@b78]) and a study of children in Tailand ([@b83]), both observed exposure levels to be at or below 1 ppb. The maximum values shown in [Table 1](#tbl1){ref-type="table"} ranged from 2 to 37 ppb. These studies demonstrate that background exposure to 2,4-D is low to undetectable in most populations. Certain individuals had the opportunity for exposure as evidenced by the maximum urinary levels. However, few of the studies collected data relevant to diet or activities to determine how the contact or exposure to 2,4-D occurred.

###### 

General population, no a priori exposure, in µg/L (ppb).

                                                                                                           Selected percentiles                               
  --------------------------------------------------- ---------------------------------- ------ ----- ---- ---------------------- ----------- ------- ------- -------------
  Centers for Disease Control and Prevention [@b20]   US 2001-2 population, Ages 6--59   2413   0.2   NR   \<LOD                  NC          \<LOD   \<1     95th = 1.3
  [@b48]                                              Canadian population, Ages 6--79    5480   NR    95   \<LOD                  NC          \<LOD   \<LOD   95th \< LOD
  [@b49]                                              US adults                          983    1     88   \<LOD                  (\<1)       \<LOD   \<LOD   37
  [@b78]                                              NC adults                          66     0.2   14   \<1                    NR          \<1     1       5
  [@b78]                                              OH adults                          69     0.2   13   \<1                    NR          1       1       8
  [@b78]                                              NC children                        66     0.2   12   \<1                    NR          \<1     1       3
  [@b78]                                              OH children                        69     0.2   3    \<1                    NR          1       2       13
  [@b83]                                              Tailand children                   207    0.5   83   NR                     \<1 (\<1)   \<1     NR      3

AM, arithmetic mean; GM, geometric mean; LOD, limit of detection; NC, not calculated; NR, not reported.

Bystanders, indirect exposure
-----------------------------

There are a number of urinary measurements collected from groups of individuals considered to be bystanders ([Table 2](#tbl2){ref-type="table"}). These individuals do not mix, load or apply 2,4-D, but may have the opportunity for indirect exposure over and above the general population. Examples include spouses and children of applicators, as well as applicators who apply other herbicides. The largest study reported that urinary 2,4-D was detected (LOD = 0.2 ppb) in all but 2% of 196 farm workers ([@b11]) although actual urinary levels were not reported. Another large study of 125 spouses of farmer applicators observed that most of the individuals were below 1 ppb ([@b9]). Other studies of women reported the geometric mean 2,4-D level to be 1 pbb or less ([@b42]; [@b22]; [@b3]). The monitoring levels of bystander children were slightly higher than the parents ([@b8]; [@b3]; [@b10]). However, a few children and spouses were involved in the application process, invalidating their classification as "bystanders." The remaining bystander studies collected urine from crop applicators before the application ([@b3]) or from crop applicators that applied other products ([@b7]; [@b23]; [@b82]; [@b13]) and licensed applicators in Minnesota ([@b37]). In general, the central tendency for urinary levels among these applicator bystanders was from less than LOD to 3 ppb.

###### 

Bystanders and rural populations, source of exposure expected to be indirect, in µg/L (ppb).

                                                                                                      Selected percentiles                                      
  -------- ---------------------------------------------------------- ------------------- ----- ----- ---------------------- ---------- ------- ------- ------- ------------------------------------------------------------------------------------------------
  [@b3]    Crop applicator, pre-application                           34                  1.0   30    NR                     4          2       NR      231     
  [@b3]    Children of applicator day 2                               52                  1.0   11    NR                     4          3       NR      263     20 children were present during the application process, 4 had opportunity for direct contact.
  [@b3]    Spouses of applicator day 2                                34                  1.0   32    NR                     1          1       NR      25      8 spouses were present during the application process, 1 had opportunity for direct contact.
  [@b7]    Crop applicator did not use 2,4-D                          83                  1.0   NR    \<LOD                  1          \<LOD   1       66      
  [@b7]    Children of applicator day 2                               92                  1.0   86    NR                     (1.9)      NR      \<LOD   100     Child with highest concentration was directly involved in the handling of the herbicide.
  [@b9]    Spouses of applicator day 2                                125                 1.0   86    NR                     1(2)       \<LOD   \<LOD   100     Spouse with the highest concentration helped with the handling of the herbicide
  [@b10]   Children of farm worker                                    60                  0.2   58    NR                     NR         \<1     NR      NR      Only % detected reported
  [@b11]   Farm worker                                                196 (784 samples)   0.2   2     NR                     NR         NR      NR      NR      Only % detected reported, 4 samples per person, 30% had all 4 detections
  [@b13]   Crop applicator of atrazine, Pre season                    30 (61 samples)     0.2   16    \<LOD                  1(3)       NR      NR      NR      90th percentile = 4
  [@b13]   Crop applicator of atrazine, planting season               30 (157 samples)    0.2   4     NR                     3(23)      NR      NR      NR      90th percentile = 67
  [@b13]   Extension agent, all seasons                               10 (49 samples)     0.2   53    \<LOD                  \<1(\<1)   NR      NR      NR      90th percentile = 2
  [@b22]   Farm worker at pregnancy delivery                          9                   20    89    NR                     NR         NR      NR      120     
  [@b23]   Crop applicator, did not use 2,4-D                         27                  0.2   30    \<LOD                  \<1        NR      NR      NR      
  [@b23]   Farmer, 2,4-D sprayed by others                            4                   0.2   0     NR                     2          NR      NR      NR      
  [@b23]   Nonfarmer                                                  45                  0.2   31    \<LOD                  \<1        NR      NR      NR      
  [@b37]   Licensed applicator, did not apply                         15                  0.6   80    \<LOD                  (0.5)      \<LOD   \<LOD   2       
  [@b42]   Household members, turf application, did not apply 2,4-D   19                  NR    100   \<LOD                  \<LOD      \<LOD   \<LOD   \<LOD   A controlled study
  [@b82]   Crop applicator (Pon Yaeng) did not use 2,4-D              67                  0.2   91    \<LOD                  NC         \<LOD   \<LOD   30      
  [@b82]   Crop applicator, (Inthakhin), not timed with application   69                  0.2   35    \<LOD                  \<1        \<1     3       598     

AM, arithmetic mean; GM, geometric mean; LOD, limit of detection; NC, not calculated; NR, not reported.

Manufacturers and applicators, direct exposure
----------------------------------------------

The occupationally exposed include individuals working in 2,4-D application on crops, forests and turf and 2,4-D manufacture ([Table 3](#tbl3){ref-type="table"}). This group is highly heterogeneous with respect to exposure due to their varying opportunity for direct exposure to 2,4-D. Most have detectable urinary levels but not all. The data for crop and forestry applicators tend to be skewed with geometric means between 5 to 45 ppb, but maximum levels from 410 to 2500 ppb ([@b60]; [@b37]; [@b7]; [@b23]; [@b3]; [@b82]; [@b15]; [@b101]). The unprotected turf applicators of liquid 2,4-D had the highest urinary levels reported in a controlled study ([@b42]). The highest levels in another turf study were observed during the spring season, compared to the summer and fall ([@b45]). Other exposure studies of professional turf applicators reported internal dose estimates and are not directly comparable to the studies in [Table 3](#tbl3){ref-type="table"} ([@b43], [@b44]). However, modeling of the variation of exposure in these reports confirmed that doses were Influenced by type of spray nozzle and use of gloves whereas job title alone was a poor determinant. Only one older study evaluated exposure among manufacturers in the 1980s ([@b61]). This population had the highest range with a maximum of 12,963 ppb.

###### 

Applicators, source of exposure expected to be direct, in µg/L (ppb).

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                            Selected percentiles                                       
  --------- ---------------------------------------------- ------------------- ----- ------ ---------------------- ---------- ------- ------- -------- ------------------------------------------------------------------------------------------------------------------
  [@b3]     Crop applicator, Day 2                         34                  1     3      13                     45         80      145     2236     Levels associated with glove use, repairing equipment and acres treated.

  [@b7]     Crop applicator, Day 1                         43                  1     52     1                      5          6       13      410      Levels associated with protective gear, application equipment, handling practice, and personal hygiene practice.

  [@b15]\   Seasonal applicator                            31 (136 samples)    1     NR                            63(259)    94              2857     16% of between worker variance explained by method, month, concentration, gloves
  [@b30]                                                                                                                                               

  [@b23]    Crop applicator                                16                  0.2   6                             13                                  Levels associated with time since application, amount applied, and acres treated

  [@b37]    Forestry applicator                            24                  0.6   1      20                     49         61      145     1700     Levels associated with application method

  [@b42]    Turf home applicators; granular, unprotected   11                  4     1/11   \<LOD                  (9.8)      \<LOD   \<LOD   108      

  [@b42]    Turf home applicators; granular, unprotected   9                   4     1/9    \<LOD                  \(19\)     \<LOD   \<LOD   169      

  [@b42]    Turf home applicators; liquid, unprotected     11                  4     2/11   \<LOD                  \(9\)      \<LOD   \<LOD   63       

  [@b42]    Turf home applicators; liquid, unprotected     9                   4     6/9    85                     \(204\)    111     289     744      

  [@b45]    Turf applicators 24-h urine samples            135 (513 samples)         42                                       15              3658     

  [@b61]    Manufacturers, 1985--1986,                     41                  1     0      332                    \(1345\)   731     1391    12,963   Within frst two hours of working shift (Friday)

  [@b60]    Crop applicator, Day 3                         2                   0.5   0                             \(1317\)                   2480     

  [@b60]    Forestry applicator, Pilot, Day 1              1                   0.5   0      NA                     NA         NA      NA      52       

  [@b60]    Forestry, mixer-loader, Day 1                  1                   0.5   0      NA                     NA         NA      NA      365      

  [@b69]    Crop applicator                                32                  NR    NR     NR                     \(9000\)   NR      NR      NR       Poor information on methods

  [@b82]    Crop applicator, not timed with application    45                        35     \<LOD                  \<1        \<1     3       598      

  [@b101]   Crop applicator, Day 5                         26                  0.2   0      NR                     17         NR      NR      2500     Lower GM levels associated with glove use and application method.
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AM, arithmetic mean; GM, geometric mean; LOD, limit of detection.

Summary of biomonitoring
------------------------

In general, urinary levels of 2,4-D are correlated with individual behavior, performed tasks and opportunity for direct contact with the herbicide. Urinary 2,4-D levels are near or below 1 ppb in most of the sampled general populations. Many of the studies of bystanders and applicators reported information on activities, use of protective equipment and application methods. The highest urinary levels were observed in "bystanders" with opportunity for direct contact with 2,4-D by assisting with the application, being present during the application, handling the herbicide ([@b8], [@b9]; [@b3]). Work practices among applicators were also demonstrated to predict urinary 2,4-D. These include glove use, repairing equipment, application method, acres treated and personal hygiene practices. In seasonal applicators, [@b15] observed that these factors explained only 16% of the variance between workers suggesting that other factors remain to be identified.

Exposure classifications in epidemiology studies can be strengthened and validated by means of high quality biomonitoring data. Currently, pesticide exposure in epidemiology studies is frequently based upon unvalidated self-reported use and/or activities with probable contact with herbicides. From a given publication, it is often difficult to differentiate if a participant applied 2,4-D or was near an application and thus assigned as "exposed." Epidemiologists are always concerned about reporting and recall bias. However, the 2,4-D urinary biomonitoring studies suggest that we can also be focused on collecting better data relevant to the application. Biomonitoring studies of applicators and their spouses have established that contact with 2,4-D through mixing, loading and applying is a strong determinant of internal exposure whereas living near the application is not ([@b7]; [@b9]; [@b3]).

For example, in their study of NHL, [@b46] measured levels of 2,4-D in household dust from vacuum cleaner bags and subsequently calculated risk estimates by dust levels in quintiles from below detection to greater than 10,000 ng/g. However, without corresponding urinary monitoring, no internal dose estimates are possible. Levels of 2,4-D in carpet dust and urine were collected in another study by [@b78]. Although 2,4-D was detected in more than 80% of the samples, with a maximum level of 21,700 ng/g, urine levels were not statistically significantly correlated with the 2,4-D concentrations in the dust samples. Whereas, 2,4-D can be identified in household dust, detection has not been demonstrated to be a good predictor of exposure based on urinary levels, and its use in epidemiology studies should be viewed with caution. This is consistent with the conclusions of [@b23] that the key determinant for exposure is actually applying the pesticide of interest.

In conclusion, the biomonitoring data for 2,4-D provide important information about the plausibility and validity of exposure estimates in the epidemiology literature.

Human health endpoints
======================

Cancer
------

### Cancers afecting the lymphatic system (NHL, MM, leukemia)

The focus of cancer studies and 2,4-D has historically addressed the lymphatic system, and primarily non-Hodgkin lymphoma (NHL). The current decade is no different with 9 case--control studies (12 publications) reporting on lymphohematopoeitic cancers ([Table 4](#tbl4){ref-type="table"}). The largest NHL study is the Italian multicenter investigation with 1575 cases reported in 2003 and 1925 cases by 2006 ([@b73], [@b74]). The estimate among all participants demonstrated no increased risk from 2,4-D use (OR = 0.9, 95% CI = 0.5--1.8). The odds ratios were not significant when stratifed by men (0.7, 95% CI = 0.3--1.9) and women (1.5, 95% CI = 0.4--5.7). Nine cases and 3 controls reported 2,4-D use (greater than low) and not using protective equipment. The large odds ratio of 4.4 was statistically significant but imprecise (95% CI = 1.1--29.1).

###### 

Carcinogenicity: summary of findings of 2,4-D exposure and cancer.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year                                                                Design                      Exposure                                                      Exposed cases              Results                                                                                               Comments/conclusions
  --------------------------------------------------------------------------- --------------------------- ------------------------------------------------------------- -------------------------- ----------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------
  [@b2]                                                                       Nested C--C\                Applied 2,4-D (self report)                                   NR                         Data not shown                                                                                        No signifcant increase, AHS Very large sample size (566 cases, 54 766 controls)
                                                                              Prostate cancer                                                                                                                                                                                                            

  [@b14]                                                                      Nested C--C\                Ever exposed to 2,4-D (self report and job exposure matrix)   11                         OR = 2.72 (1.12--6.57)\                                                                               Results inconsistent.\
                                                                              Prostate cancer                                                                                                      Dose response not signifcant (not shown)                                                              Large sample size (1153 cases and 3999 controls

  [@b16]                                                                      Cohort                      Worked in chlorophenoxy                                                                  Hazard ratios for Factory A:                                                                          No signifcant increase

                                                                              All cancers                 manufacturing                                                 81                         All cancers: 1.31 (0.86--2.01)                                                                        Moderate cohort (Factory A = 539 exposed, 18 811 person years and Factory B = 411 exposed, 12 946 person years)

                                                                              NHL                                                                                       4                          NHL: 0.92 (0.19--4.47) (1 case in Factory B)                                                          Not specifc to 2,4-D, exposures include 2,4,5-T, MCPA, other pesticides and possibly TCDD.

                                                                              Stomach                                                                                   5                          Stomach: 2.23 sibly TCDD. (0.38--13.20)                                                               

                                                                              Melanoma                                                                                  3                          Melanoma: 0.72 (0.07--7.03)                                                                           

                                                                              Prostate                                                                                  6                          Prostate: 2.93 (0.61--14.15)                                                                          

  [@b17]                                                                      Cohort                      Worked in 2,4-D                                                                          SIR for Cohort 2                                                                                      No signifcant increase

                                                                              All cancers                 manufacturing                                                 244                        All cancers: 0.88 (0.78--1.00)                                                                        Signifcant defcit of prostate cancer

                                                                              NHL                                                                                       14                         NHL 1.36 (0.74--2.29) 14 cases                                                                        Other exposure include benzene, asbestos and possibly TCDD

                                                                              Stomach                                                                                   4                          Stomach: 0.85 (0.23--2.18)                                                                            Moderate cohort of 1256 workers, 23 354 person years)

                                                                              Melanoma                                                                                  9                          Melanoma: 1.06 (0.48--2.01)                                                                           

                                                                              Brain cancer                                                                              3                          Brain: 0.87 (0.17--2.54)                                                                              

                                                                              Prostate                                                                                  62                         Prostate: 0.74 (0.57--0.94)                                                                           

  [@b19]                                                                      C-C                         Exposed to 2,4-D on a farm (self-report)                      24                         OR = 0.9 (0.5--1.6) including proxy                                                                   No signifcant increase

                                                                              Glioma                                                                                    11                         OR = 0.8 (0.4--1.6) excluding proxy                                                                   Moderate sample size (341 cases, 527 controls)

  [@b21][a](#tf4-1){ref-type="table-fn"}; See Lee et al. (2004a) and [@b24]   C--C\                       Used phenoxy herbicides (self-report)                                                    T(14:18) positive No use: OR = 5.0 (1.2--20.8)                                                        Results inconsistent. Not specifc to 2,4-D
                                                                              NHL by t(14:18) status                                                                                                                                                                                                     

                                                                                                                                                                        14                         Used: OR = 2.9 (1.0--8.4)\                                                                            Risk from no use higher than risk of use\
                                                                                                                                                                                                   T(14:18) negative\                                                                                    Large sample size (172 cases, 1432 controls)\
                                                                                                                                                                                                   No use: OR = 1.5 (0.5--4.8)                                                                           All pesticide analyses higher for t(14:18) positive status than negative

                                                                                                                                                                        Used OR = 0.8 (0.4--1.6)                                                                                                         

  [@b24][a](#tf4-1){ref-type="table-fn"}; See [@b21] and [@b65]               C--C NHL                    Used 2,4-D (self-report)                                      123                        OR = 0.9 (0.6--1.2)\                                                                                  No signifcant increase\
                                                                                                                                                                                                   No increase both malathion and 2,4-D                                                                  Large sample size (870 cases, 2569 controls)

  [@b25]                                                                      Nested C--C Melanoma        Applied 2,4-D (self report)                                   NR                         data not shown                                                                                        No signifcant increase, AHS Very large sample size (150 cases and 24 554 noncases)

  [@b27]                                                                      Nested C--C Breast cancer   Applied 2,4-D (self report)                                   41                         Adj RR 0.8 (0.6--1.1) (also by state and menopausal status)                                           No signifcant increase, AHS Very large sample size (309 cases, 30 145 noncases)

  [@b28]                                                                      C-C                         Used 2,4-D and/or 2,4,5-T (self-report)                       33                         Multivariate OR = 1.24 (0.68--2.26)                                                                   No signifcant increase

                                                                              NHL and specifc entities                                                                  21                         OR = 2.08 (0.99--4.38) for ≤ 29 days                                                                  Large sample size (910 cases, 1016 controls)

                                                                                                                                                                        12                         OR = 1.33 (0.57--3.13) for \>29 days.\                                                                Signifcant results for phenoxy herbicides driven by MCPA results.
                                                                                                                                                                                                   Non signifcant Ors for 8 entities                                                                     

  [@b31]                                                                      Nested C--C                 Parent used 2,4-D (self-report by parent)                     7                          Mother used OR = 0.72 (0.32--1.60)                                                                    No signifcant increase, AHS

                                                                              Cancer in children                                                                        26                         Father used OR = 1.29 (0.71-2.35)                                                                     Large sample size (17 280 children) 50 cancer cases, 2 NHL cases

  [@b46]                                                                      C-C                         2,4-D in carpet dust                                          257                        OR = 1.10 (0.78--1.55) \<500 ng/g in dust                                                             No signifcant increase

                                                                              NHL                                                                                       86                         OR = 0.91 (0.58-1.45) 500-999 ng/g                                                                    Large sample size (1321 cases, 1057 controls; with dust 679 cases, 510 controls)

                                                                                                                                                                        165                        OR = 0.66 (0.45-0.98) 1000-9999 ng/g                                                                  

                                                                                                                                                                        24                         OR = 0.82 (0.41-1.66) \>10,000 ng/g                                                                   

  [@b51]; See [@b71], [@b72][a](#tf4-1){ref-type="table-fn"}                  C-C                         Used 2,4-D (self-report)                                      49                         2,4-D alone OR = 0.94 (0.67-1.33)                                                                     Risk only in combination

                                                                              NHL                                                                                       61                         Malathion and 2,4-D OR = 2.06 (1.45--2.93)                                                            Large sample size (513 cases, 1506 controls)

  [@b65][a](#tf4-1){ref-type="table-fn"}; See [@b21] and                      C-C                         Used 2,4-D (self-report)                                      172                        Non asthmatics OR = 1.0 (0.8-1.3)                                                                     No signifcant increase

  [@b24]                                                                      NHL                                                                                       17                         Asthmatics OR = 1.3 (0.7--2.5)                                                                        Large sample size (872 cases, 2381 controls)\
                                                                                                                                                                                                                                                                                                         Asthmatics tended to have higher Ors for many other pesticides

  [@b67]                                                                      C-C                         Used 2,4-D (self report)                                      25                         Proxy OR = 3.3 (1.5--7.2)                                                                             Potential recall bias in proxies

                                                                              Glioma                                                                                    7                          Self OR = 0.6 (0.2--1.6)                                                                              Moderate sample size (251 cases, 498 controls)

  [@b66]                                                                      C-C                         Used 2,4-D (self-report)                                      27                         Stomach OR = 0.8 (0.4--1.3)                                                                           No signifcant increase

                                                                              Stomach, Oesophagus                                                                       20                         Oesophagus OR = 0.7 (0.4--1.2)\                                                                       Moderate sample size (170 stomach, 137 oesophagus, 502 controls)\
                                                                                                                                                                                                   Proxy respondents for 80% of stomach and 76% of oesophageal cases                                     Potential recall bias in proxies

  [@b68]                                                                      Nested                      Used 2,4-D (self-report)                                      135                        Colon OR = 0.6 (0.4--0.8), also signifcant by lifetime exposure days (*p* = 0.011)                    Signifcant inverse association for colon, AHS

                                                                              C-C Colorectal                                                                            69                         Rectum OR = 1.1 (0.6--2.0)                                                                            Very large sample size (305 cases, 56 508 noncases)

  [@b71][a](#tf4-1){ref-type="table-fn"}                                      C-C                         Used 2,4-D (self report)                                      111                        Adj OR = 1.32 (1.01-1.73)                                                                             Results inconsistent

                                                                              NHL                         More than 10 hours per year                                                              No dose response by days per year Conditional, most parsimonious model excluded phenoxy herbicides.   Large sample size (517 cases, 1506 controls)\
                                                                                                                                                                                                                                                                                                         Results confounded by other factors

  [@b72][a](#tf4-1){ref-type="table-fn"}                                      C-C\                        Used 2,4-D (self-report)\                                     37\                        Exp to 2,4-D, no DEET OR = 1.05\                                                                      No signifcant increase\
                                                                              NHL                         More than 10 hours per year                                   73\                        (0.69-1.6)\                                                                                           Large sample size (513 cases, 1506 controls)\
                                                                                                                                                                        20                         Both 2,4-D and DEET OR = 1.17 (0.84--1.64) Glove,2,4-D and DEET OR = 1.77 (0.90--3.45)                OR highest when used rubber gloves.

  [@b73][a](#tf4-1){ref-type="table-fn"}                                      C-C                         Exposed to 2,4-D (Expert assessment from self-report)         6                          Men OR = 0.7 (0.3--1.9)                                                                               No signifcant increase

                                                                              NHL                                                                                       7                          Women OR = 1.5 (0.4--5.7)                                                                             Large sample size (1575 cases, 1232 controls)

  [@b74]; See [@b73][a](#tf4-1){ref-type="table-fn"}                          C-C                         Exposed to 2,4-D (Expert assessment from self-report)         17                         Overall OR = 0.9 (0.5-1.8)                                                                            Results imprecise

                                                                              NHL                                                                                       9                          Lack of protective equipment OR = 4.4 (1.1--29.1)                                                     Large sample size (1925 cases, 1232 controls)

  [@b76]                                                                      C-C                         Work records matched with use registry                                                   Cases diagnosed \<1995                                                                                Results inconsistent by diagnosis date. OR\'s similar for low and high use.

                                                                              Breast cancer                                                                             12                         OR = 0.61 (0.20--1.86) for low use                                                                    Exposure subject to misclassifcation: assumed from working in felds but metrics not timed with application and entry.

                                                                                                                                                                        8                          OR = 0.62 (0.23-1.69) for high use Cases diagnosed ≥1995                                              Moderate sample size (128 cases, 640 controls)

                                                                                                                                                                        19                         OR = 2.16 (0.95--4.93) for low use                                                                    

                                                                                                                                                                        21                         OR = 2.14 (1.06--4.32) for high use                                                                   

  [@b75]                                                                      C-C                         Work records matched with use registry                        NR                         NHL High (v Low) OR = 3.8 (1.85-7.81)                                                                 Results imprecise (only 15% exposed to 2,4-D)

                                                                              NHL, MM, Leukemia                                                                                                    NHL extranodal OR = 9.73 (2.68--35.3)                                                                 Exposure subject to misclassifcation: assumed from working in felds but metrics not timed with application and entry.

                                                                                                                                                                                                   NHL males OR = 3.79 (1.58--9.11)\                                                                     Moderate sample size (60 NHL, 51 leukemia, 20 MM cases and 5 controls per case)
                                                                                                                                                                                                   NHL females OR = 5.23 (1.3--20.9) *N* = 15\                                                           
                                                                                                                                                                                                   Leukemia OR = 1.03 (0.41--2.61)\                                                                      
                                                                                                                                                                                                   MM, "no elevated risks"                                                                               

  [@b77]                                                                      C-C                         Work records matched with use registry                        17                         Signifcant at lowest pounds of use                                                                    Results inconsistent for reference and no dose response.

                                                                              Gastric (stomach) cancer                                                                  14                         OR = 2.16 (1.02-4.56) for 1--14 lbs                                                                   Moderate sample size (100 cases, 210 controls)

                                                                                                                                                                        11                         OR = 1.57 (0.71--3.51) for 15--86 lbs\                                                                Exposure subject to misclassifcation: assumed from working in felds but metrics not timed with application and entry.
                                                                                                                                                                                                   OR = 2.09 (0.87--5.05) for 86--1950 lbs\                                                              
                                                                                                                                                                                                   No increase using low as the reference.                                                               

  [@b80] and [@b81]                                                           C-C                         Used 2,4-D (self report)                                      57                         HL OR = 0.96 (0.67--1.37)                                                                             No signifcant increase

                                                                              HL, MM, STS                 More than 10 hours per year                                   80                         MM OR = 1.21 (0.89--1.65)                                                                             Large sample size (316 HL, 342 MM, 357 STS, 1506 controls)

                                                                                                                                                                        69                         STS OR = 0.97 (0.71--1.32)\                                                                           
                                                                                                                                                                                                   No increases if both DEET and 2,4-D                                                                   

  [@b90]                                                                      C-C                         Used phenoxy herbicides (self report)                         17                         T (14:18) positive OR = 0.9 (0.5--1.5)                                                                No signifcant increase

                                                                              NHL specifc entities                                                                      30                         T (14:18) negative OR = 1.1 (0.7--1.5)                                                                Not specifc to 2,4-D Large sample size (622 cases, 182 cases with translocation status, 1245 controls)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Same population.

C--C, case--control study; HL, Hodgkin lymphoma; MM, Multiple myeloma; NR, not reported; STS, soft tissue sarcoma.

Case--control size: Very large (\>10 000); Large (\>1000); Moderate (\>100). Cohorts small (\<10 000 person years at risk).

Another large NHL case--control study from Sweden, ([@b28]) reported no statistically significant increased risk for 2,4-D and/or 2,4,5-T use among 910 cases and 1016 controls. Tere was no increase in odds ratios by days used nor any significant increase by any of eight cancer entities. A statistically significant risk for NHL and phenoxy herbicides, in general, was Influenced by the significant odds ratios for MCPA.

Data were pooled from three previously published case--control studies in Kansas ([@b50]), Nebraska ([@b113]) and Iowa and Minnesota ([@b18]) resulting in 870 NHL cases and 2569 controls ([@b24]; [@b65]). There were 123 cases and 314 controls who reported using 2,4-D. No significant increases for using 2,4-D and NHL were reported in analyses to address possible associations among asthmatics and adjusting for co-exposure to other pesticides ([@b24]; [@b65]). Another similarly sized study (679 cases and 510 controls) reported no significant increase in risk of NHL and 2,4-D in carpet dust ([@b46]).

A large case--control study of 517 NHL cases and 1506 controls from six Canada provinces observed a statistically significant odds ratio for 2,4-D use after adjusting for medical variables (OR = 1.32, 95% CI = 1.01--1.73) ([@b71]). However, multivariate analyses and stratification by days of use yielded no statistically significant results. In their analyses of the use of the insect repellent, DEET (N,N-diethyl-m-toluamide) the authors reported no statistically significant increase for NHL and 2,4-D ([@b72]). The odds ratio for using gloves, 2,4-D and DEET was 1.77 (95% CI = 0.90--3.45). The authors discuss that DEET may increase permeability of rubber gloves. However, one would expect a similar or equal risk compared to no glove use, not higher. The analyses of these data by [@b51] reported an increased odds ratio among respondents who used both malathion and 2,4-D (OR = 2.06, 95% CI = 1.45--2.93). This is in contrast with the pooled study of [@b24] that reported no association for use of both pesticides.

The studies by [@b90] and [@b21] evaluated t(14:18) subtypes of NHL in case--control studies in Iowa/Minnesota, and Nebraska. Neither evaluated 2,4-D specifically and only reported use of phenoxy herbicides. [@b90] reported no increased risk for the t(14:18) positive subtype (OR = 0.9, 95% CI = 0.5--1.5).

The smallest case--control study published in the past decade was the United Farm Worker analysis of 60 cases of NHL ([@b75]). With the small sample size and only 15% of the subjects classified as exposed to 2,4-D, the results are imprecise. For example, the confidence interval for the NHL-extranodal association (OR = 9.73, 95% CI = 2.68--35.3) is very wide (confidence interval ratio = 13).

Two occupational cohort studies of workers in 2,4-D and phenoxy herbicide manufacturing have been updated since the 2001 review. Neither study reported a statistically significant increase in NHL ([@b16]; [@b17]). The cohort of foresters was too small for a meaningful evaluation of 3 NHL cases ([@b102]).

Other lymphohematopoetic cancers such as leukemia, Hodgkin lymphoma and multiple myeloma were also investigated and also were not found to be associated with 2,4-D exposure ([@b75]; [@b80]; [@b16]; [@b17]).

In summary, since 2001, there have been 9 epidemiology studies to investigate the association of 2,4-D and NHL and only 2 reported a statistically significant positive association ([@b72]; [@b75]). The largest, most robust studies found no dose response and no statistically significant increase in use of 2,4-D and NHL. The few statistically significant results reported were internally inconsistent with other dose and multi-variate analyses in the same study, were imprecise and were not confirmed in studies of other populations. These studies provide inconsistent evidence of increased risk of NHL or other cancers of the lymphatic system.

### Other cancers

The inconsistencies in the epidemiology data are often attributed to poor quality and inadequate sample size. The Agricultural Health Study (AHS) was designed to address these inadequacies by enrolling approximately 90 000 farmer applicators and their spouses. Tere are more than 100 publications from the AHS (<http://aghealth.nci.nih.gov/>). Although the AHS has not reported on 2,4-D applicators as a group specifically, nested case--control studies of prostate cancer, breast cancer, colorectal cancer, melanoma of the skin and childhood cancer have evaluated 2,4-D. None of these studies reported an association with 2,4-D. Each is detailed below by cancer site. In addition to the AHS publications, other studies that report these cancer sites and 2,4-D are also discussed ([Table 4](#tbl4){ref-type="table"}).

The prostate cancer case--control study nested in the AHS reported no significant increase use of 2,4-D by cases ([@b2]). The much smaller Dutch manufacturing cohort also reported no significant increase ([@b16]) and the other manufacturing cohort reported a statistically significant defcit of prostate cancer among 2,4-D workers ([@b17]). Exploratory analyses in a recent case--control study were strong and statistically significant (OR = 2.72, 95% CI = 1.12--6.57) but with only 12 exposed cases, dose-response analyses were not examined ([@b14]). Together, these studies provide inconsistent evidence of increased risk of prostate cancer and 2,4-D exposure.

No significant increase of breast cancer was reported by the [@b27] analysis of the AHS women who reported using 2,4-D. This is in contrast to a UFW case--control study that reported a statistically significant odds ratio of 2.14 (95% CI = 1.06--4.32) for cases diagnosed after 1994 ([@b75]). However, the odds ratio was inexplicably less than expected for early diagnosed (before 1994) cases (OR = 0.6, 95% CI = 0.23--1.69). There was no dose response since the ORs were similar for low and high use. Exposure misclassification may exist in this study since exposures were assumed for all farm workers and the determination of 2,4-D exposure was not timed by application or entry into the feld. These studies of breast cancer in women are inconsistent.

Cancers of the colon and rectum were evaluated in the AHS by [@b68]. No significant increase was reported for rectal cancer and a statistically significant inverse dose response by lifetime exposure days (*p* = 0.011) was observed for colon cancer and 2,4-D. The manufacturing cohorts of [@b16] and [@b17] reported no significant increases. These studies provide no evidence of increased risk of colorectal cancer.

[@b25] reported no significant increase in or risk melanoma of the skin associated with 2,4-D exposure. This is consistent with both the Dutch and US 2,4-D manufacturing cohorts ([@b16]; [@b17]). These studies provide no evidence of increased risk of melanoma.

A study of children of participants of the AHS who ever applied 2,4-D was reported by [@b31]. No sig-nifcant increase in cancer was observed.

The association of 2,4-D exposure and two other cancer sites have been addressed by other non AHS studies. A statistically significant association was reported by Lee et al. among glioma proxy respondents (OR = 3.3, 95% CI = 1.5--7.2) but not among self respondents (OR = 0.6, 95% CI = 0.2--1.6). There may be appreciable recall bias ([@b67]). No significant increase for 2,4-D and glioma was reported by [@b19]. The risk of brain cancer was also not increased in the 2,4-D occupational cohort ([@b17]). These studies provide inconsistent evidence of increased risk of brain cancer.

No significant association between stomach and oesophageal cancers and 2,4-D exposure was reported in a case--control study ([@b66]) and the results were inconsistent for stomach cancer in the UFW case--control study by [@b77]. Neither the Dutch nor the US occupational cohort study reported significant increased risk of stomach cancer ([@b16]; [@b17]). These studies provide inconsistent evidence of increased risk of stomach cancer

Reproductive toxicity
---------------------

Using a cross sectional design, [@b96] evaluated urinary 2,4-D levels, semen quality, sperm concentration, morphology, and motility in a multi-center study of partners of pregnant women ([Table 5](#tbl5){ref-type="table"}). They found no significant associations in semen quality, concentration, morphology or motility with 2,4-D levels. An exposure study of 2,4-D farmers did identify 2,4-D in the sperm of study participants ([@b4]). These findings are difficult to interpret with respect to farmer practices because detectable levels were found in over 50% of the subjects with no reported use of 2,4-D and nearly half of those who did report using 2,4-D were below detection (summarized in [Table 5](#tbl5){ref-type="table"}).

###### 

Reproductive toxicity: summary of findings of 2,4-D exposure and reproductive endpoints.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                                                                         Design                                   Exposure                                        Exposed cases   Results                                                                           Comment/conclusions
  ------------------------------------------------------------------------------ ---------------------------------------- ----------------------------------------------- --------------- --------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------
  [@b6][a](#tf5-1){ref-type="table-fn"}; [@b4][a](#tf5-1){ref-type="table-fn"}   Nested C--C Spontaneous abortion (SAB)   Used 2,4-D in farming during pregnancy period   26              \<12 weeks gestation\                                                             Results inconsistent\
                                                                                                                                                                                          Preconception exposure OR = 1.3 (0.9--2.0)                                        Large sample size (395 SAB among 3936 pregnancies)

                                                                                                                                                                          9               Post conception exposure OR = 0.6 (0.3--1.2)                                      Related analysis of [@b4], "results were sensitive to the cutpoint used" (12 vs. 13 weeks gestation)

                                                                                                                                                                          22v5            Pre vs. Post OR = 2.9 (1.1--8.0)                                                  

                                                                                                                                                                          11v14           12--19 weeks, Pre vs. Post OR = 0.5 (0.2--1.1)                                    

  [@b96]                                                                         Nested C--C                              Urinary 2,4-D (≥0.1 µg/g cr)                    5               Low semen quality OR = 0.8 (0.2--3.0) (Missouri, no exposed cases in Minnesota)   No significant increase

                                                                                                                          Semen quality                                                   Concentration, morphology, % motile (all *p* values \>0.05)                       Small sample size (65 cases and 101 controls with semen samples)

  [@b106]                                                                        C--C                                     2,4-D in surface water (\>70 µg/L)              NR              OR = 1.05 (0.81--1.37) \<10 km to water                                           No significant increase

                                                                                                                          Gastroschisis (birth deffect)                                                                                                                     Large sample size (805 cases, 3616 controls)

  [@b107][a](#tf5-1){ref-type="table-fn"}                                        Nested C--C                              Used 2,4-D in farming during pregnancy period                   In ofspring:                                                                      Significant only for hayfever/allergies

                                                                                 Allergies, hayfever in ofspring                                                          21              Bronchitis OR = 1.46 (0.80--2.66)                                                 Large sample size (805 children)

                                                                                                                                                                          24              Asthma OR = 0.74 (0.38--1.43)                                                     Since a farming family, exposure not restricted to in utero.

                                                                                                                                                                          52              Hayfever/allergies OR = 1.66 (1.11--2.49)                                         

  [@b108][a](#tf5-1){ref-type="table-fn"}                                        Nested C--C                              Used 2,4-D in farming during pregnancy period   7               Any deffect OR = 0.97 (0.42--2.25)                                                No significant increase

                                                                                 Birth deffects                                                                           6               Pre-conception OR = 0.60 (0.25--1.46)                                             Large sample size (118 malformation in 3412 pregnancies
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Same cohort.

C--C, case--control study; NR, not reported.

To our knowledge, the only other study to evaluate semen quality and 2,4-D exposure is a small study of 32 farmers and 25 controls ([@b69]). Using urine and sperm samples collected during a growing season, the authors reported differences in sperm quality at one stage but not another among 2,4-D exposed farmers compared to controls. The validity and generalizability of this study, however, are questionable. The study conduct was poorly described making evaluation of the study quality impossible. No information was provided about timing of either the urine or semen collection with respect to 2,4-D application. Lastly, the mean urinary levels of the exposure group at 9.0 mg/L (9000 ppb) are 200 to 500 times higher than the mean levels measured in other farmer studies ([@b3]; [@b101]). It is unclear if this is due to unique practices or incorrect analytical methods. Regardless, from a dose interpretation, these urinary levels are unanticipated for current farmers. These few publications provide no convincing evidence for sperm cell toxicity in humans from 2,4-D exposure.

Only one study evaluated rates of spontaneous abortion following use of 2,4-D during the pregnancy period ([@b4]; [@b6]). The overall results showed no association with 2,4-D use in the preconception period (OR = 1.2, 95% CI = 0.8--1.6) or the postconception period (OR = 1.0, 95% CI = 0.7--1.6). A single analysis comparing pre- and post-conception exposure less than 12 weeks gestation was statistically significant (OR = 2.9, 95% CI = 1.1--8.0). The results were sensitive to the use of 12 or 13 weeks as the cutpoint for exposure period suggesting a random finding.

Three studies evaluated birth deffects but none identified a significant increase with 2,4-D exposure ([@b88]; [@b108]; [@b106]). A publication on respiratory endpoints in children whose parents used 2,4-D during the pregnancy period reported a significant prevalence of hay fever and/or allergies (OR = 1.66, 95% CI = 1.11--2.49). However, the study did not evaluate and cannot exclude exposure to allergens after birth ([@b107]). These studies provide no evidence of increased risk of birth deffects due to 2,4-D exposure.

Genotoxicity, including hormones and immune system
--------------------------------------------------

A few investigators have reported on cytogenetic damage among agricultural workers, but none was specific to 2,4-D exposure ([@b34], [@b35], [@b36]; [@b38]; [@b70]; [@b86]; [@b115]). A small study of farmer applicators reported no association with micronuclei scores, lymphocyte phe-notypes and blood counts ([@b30]). Some estimates of replicative index were significantly associated with urinary 2,4-D levels but others were not. These findings do not support the hypothesis of changes in immunological variables after a 2,4-D application ([@b29]). Another small study identified an association with luteinizing hormone (LH) levels and urinary 2,4-D levels, but found no additional associations with hormone levels or chromosomal aberrations ([@b37]). Neither study finding has been confirmed by other independent investigations. No significant increase in antinuclear antibodies positivity among 2,4-D users was reported in the cross sectional study by [@b91] (summarized in [Table 6](#tbl6){ref-type="table"}).

###### 

Genotoxicity: summary of findings of 2,4-D exposure and genetic, hormone, and immune related endpoints.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author   Design                                                                              Exposure                              Exposed cases   Results                                                                                                                                                             Comments/conclusions
  -------- ----------------------------------------------------------------------------------- ------------------------------------- --------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------
  [@b30]   Cross sectional                                                                     Urinary 2,4-D in farmer applicators   12              Micronuclei scores, lymphocyte phenotypes, blood counts not significant.                                                                                            Results inconsistent

           Micronuclei, replicative index (RI), lymphocyte phenotypes, complete blood counts                                                         Replicative index (RI)                                                                                                                                              Only RI significant before/after and appl/control, no dose response

                                                                                                                                                     Before/after (*p* = 0.016) Applicator/control (*p* = 0.046) Trend by urinary level (*p* = 0.15)                                                                     Small sample size (12 applicators, 9 controls)

  [@b37]   Cross sectional                                                                     Urinary 2,4-D and work records        21              LH correlated with urinary levels (*p* = 0.006)                                                                                                                     Small sample size (24 applicators, 15 controls)

           Hormone levels, chromosomes aberrations                                                                                                   FSH, testosterone, chromo-some aberrations not cor-related with urinary levels V(D)J rearrangement frequency correlated with urinary levels by application method   Exposure according to application method

  [@b91]   Cross sectional Antinuclear antibodies (ANA)                                        Used 2,4-D (occupational)             50\             OR = 0.70 (0.27--1.77) ANA + OR = 0.30 (0.11--0.86), men only                                                                                                       No significant increase Moderate sample size (*N* = 208)
                                                                                                                                     48                                                                                                                                                                                  
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Same cohort.

Neurotoxicity
-------------

Parkinsonism, Parkinson\'s Disease and use of 2,4-D have been evaluated in four independent studies and five publications ([@b59]; [@b26]; [@b39]; [@b97]; [@b98]). A multicenter case--control study (519 cases and 511 controls) by [@b97] reported a strong and statistically significant increased risk of Parkinsonism among 2,4-D users (OR = 2.59, 95% CI = 1.03--6.48). However further analyses by job and exposure duration did not support a dose response. No significant increase risk of 2,4-D use and Parkinson\'s Disease was identified in the other studies (summarized in [Table 7](#tbl7){ref-type="table"}).

###### 

Neurotoxicity.

  Author, year                                         Endpoint               Exposure                      Exposed Cases   Results                                                     Comments/conclusions
  ---------------------------------------------------- ---------------------- ----------------------------- --------------- ----------------------------------------------------------- ---------------------------------------------------------------------------------
  [@b26]                                               C--C                   Used 2,4-D                    17              OR = 1.2 (0.6--2.8)                                         No significant increase
                                                       Parkinson\'s disease                                                                                                             Moderate sample size (100 cases, 84 controls)
  [@b59][a](#tf7-1){ref-type="table-fn"}               Nested C--C            Used 2,4-D                    47              OR = 0.9 (0.5--1.8) prevalent                               No significant increase, AHS
                                                       Parkinson\'s disease                                 49              OR = 1.0 (0.5--2.1) incident                                Very large sample size (83 prevalent cases, 78 incident cases, 79 557 controls)
  [@b39]                                               C--C                   Used chorphenoxy acid/ester   15              OR = 2.07 (0.69--6.23)                                      No significant increase
                                                       Parkinson\'s disease                                                                                                             Large sample size (319 cases, 296 controls)
  [@b97]                                               Parkinsonism           Used 2,4-D                    16              OR = 2.59 (1.03--6. 48) No association by duration of use   Results inconsistent Moderate sample size (519 cases, 511 controls)
  [@b98][a](#tf7-1){ref-type="table-fn"}; See [@b59]   Nested C--C            Used 2,4-D                    76              OR = 1.2 (0.57--2.4)                                        No significant increase, AHS
                                                       Parkinson\'s disease                                                                                                             Moderate sample size (110 cases, 358 controls)

Same cohort.

C--C, case--control study.

General toxicity
----------------

Various respiratory endpoints have been addressed in certain groups within the AHS. These endpoints are all self-reported and include wheeze, farmer\'s lung, chronic bronchitis, asthma, and rhinitis. Only atopic asthma was associated with 2,4-D use in the AHS women and rhinitis (runny nose) in the commercial applicators. In the absence of a dose response and in the context of many co-exposures the implication of these associations for 2,4-D *per se* is unclear. No other publication has confirmed these associations (summarized in [Table 8](#tbl8){ref-type="table"}).

###### 

General toxicity.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                                    Endpoint                                                                                                       Exposure                                                   Exposed cases   Results                                                                                                     Comments/Conclusions
  ----------------------------------------- -------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------- --------------- ----------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------
  [@b53][a](#tf8-1){ref-type="table-fn"}    Nested C--C\                                                                                                   Used 2,4-D in private farming and commercial application   NR              Farmers OR = 0.97 (0.86--1.10)\                                                                             No signifcant increase, AHS\
                                            Wheeze                                                                                                                                                                                    Commercial OR = 0.99 (0.73--1.34)                                                                           Very large sample size (17 920 farmers and 2255 commercial applicators, 19 and 22% with wheeze)

  [@b52][a](#tf8-1){ref-type="table-fn"}    Nested C--C                                                                                                    Used 2,4-D in farming                                      2395            OR = 0.99 (0.88-1.11)                                                                                       No signifcant increase, AHS

                                            Wheeze                                                                                                                                                                    77              OR = 1.25 (0.83--1.90) at highest use (\>40 days)                                                           Very large sample size (3838 cases, 16 630 controls)\
                                                                                                                                                                                                                                                                                                                                                  Highest OR at highest dose

  [@b54][a](#tf8-1){ref-type="table-fn"}    Nested C--C                                                                                                    Used 2,4-D in commercial application                       225             Current use OR = 1.27 (0.96-1.68)                                                                           No signifcant increase, AHS\
                                                                                                                                                                                                                                                                                                                                                  Large sample size (486 cases, 1769 noncases)

  [@b55][a](#tf8-1){ref-type="table-fn"}    Nested C--C\                                                                                                   Used phenoxy\                                              363             OR = 1.12 (0.77-1.64)                                                                                       No signifcant increase, AHS\
                                            Farmer\'s lung                                                                                                 herbicide                                                                                                                                                                              Results not specifc to 2,4-D\
                                                                                                                                                                                                                                                                                                                                                  Large sample size (395 cases, 16 563 controls)

  [@b56][a](#tf8-1){ref-type="table-fn"}    Nested C--C\                                                                                                   Used 2,4-D in farming                                      78              OR = 1.10 (0.90-1.35)                                                                                       No signifcant increase, AHS\
                                            Chronic bronchitis                                                                                                                                                                                                                                                                                    Very large sample size (654 cases, 20 254 noncases)

  [@b57][a](#tf8-1){ref-type="table-fn"}    Nested C--C                                                                                                    Used 2,4-D in farming, women only                          52              Atopic asthma OR = 1.53 (1.12--2.10)                                                                        Signifcant increase, AHS

                                                                                                                                                           Asthma                                                     66              Nonatopic OR 1.07 (0.82--1.41)\                                                                             Very large sample size (282 atopic asthma, 420 nonatopic, 3086 atopy, 25,112 controls)
                                                                                                                                                                                                                                      Atopy alone OR = 1.20 (1.08--1.34)                                                                          

                                                                                                                                                                                                                      477             Growing up on farm OR = 0.55 (0.43--0.70)                                                                   OR \> 1 for most pesticides reported

  [@b89]                                    Cross sectional HDL, triglycerides, non-HDL, insulin, C-peptide, plasma glucose, thyroid stimulating hormone   Urinary levels in US population (\> LOD)                   102             Decreasing HDL (*p*\< 0.05), increasing TSH (*p* \< 0.05) among T4 \< 8.5.                                  Only 14% above LOD

                                                                                                                                                                                                                                      Increasing triglycerides (*p* \< 0.01), insulin (*p* \< 0.05), c-peptide (*p* \< 0.01) among HbA1c \>5.1%   Moderate sample size (*N* = 727)\
                                                                                                                                                                                                                                                                                                                                                  Endpoints within normal range\
                                                                                                                                                                                                                                                                                                                                                  Cross sectional study with very low exposure.

  [@b92][a](#tf8-1){ref-type="table-fn"}    Nested C--C Rhinitis (stufy, itchy, or runny nose in past 12 months)                                           Used 2,4-D as a commercial applicator                      750\            OR = 1.34 (1.09-1.64)\                                                                                      Results inconsistent, no dose response, AHS\
                                                                                                                                                                                                                      11              OR = 0.69 (0.25-1.89) at highest dose (≥ 60 days)                                                           Large sample size (1664 cases, months)

  [@b105][a](#tf8-1){ref-type="table-fn"}   Chronic bronchitis                                                                                             Used 2,4-D in farming, women only                          93              OR = 1.29 (1.02-1.63) adj for age, state\                                                                   Results attenuate with modeling, AHS\
                                                                                                                                                                                                                                      OR = 1.20 (0.89--1.63) multivariate                                                                         Very large sample size (583 cases, 20 958 noncases)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Same cohort.

C--C, case--control study; NR, not reported.

Another publication used the national data from the CDC to compare urinary levels in the US population to a battery of tests relevant to risk factors for heart disease. Whereas all the endpoints were within the normal range and only 14% of the subjects had 2,4-D levels above the LOD, some endpoints were statistically significantly associated with detectable urinary 2,4-D. As a cross sectional analysis of data collected at the same time for endpoints within normal, the etiologic implications are unclear. No other published study to date has tested these findings.

Summary of epidemiology
-----------------------

The 2,4-D epidemiology literature after 2001 related to carcinogenic reproductive, genotoxic, neurotoxic and general outcomes in humans is overwhelmingly negative. For cancer, the data are broad and consistent and give no credible or plausible evidence for any increased risk of cancer in humans associated with 2,4-D exposure. The most frequently reported cancer endpoint was NHL. The overall results for 7 studies reported prior to 2001 ([@b111]; [@b84]; [@b93]; [@b40]; [@b62]; [@b114]; [@b40]) and the 9 new studies reviewed since 2001 are shown in [Figure 1](#fig1){ref-type="fig"}. Unfortunately it was not possible to compare NHL results across studies by dose estimates. Several studies used duration as a proxy for increasing exposure but these maximum levels ranged from 7 days ([@b71]), 29 days ([@b28]), 5 years ([@b17]), to 17 years ([@b21]). [@b74] considered no use of protective equipment (i.e. gloves) to be the highest level whereas [@b72] categorized glove use with 2,4-D and DEET as the highest level. Overall, there are a few statistically significant positive observations, but the data are not consistent across studies, particularly in the past 10 years.

![Relative risk estimates, lower and upper limits for epidemiology studies of NHL from 1989 to 2011. (See colour version of this figure online at [www.informahealthcare.com/txc](www.informahealthcare.com/txc))](btxc42-768-f1){#fig1}

Statistical power to detect an association is Influenced by sample size of the study, numbers and magnitude of exposed and the strength of the association. One can play down a lack of statistical significance due to inadequate participants. Conversely, small studies with statistically significant and strong results may emphasize the role of statistical testing. A useful way to evaluate multiple results within and across studies is to compare the confidence interval ratio (CIR) ([@b85]). For example, as shown in [Table 9](#tbl9){ref-type="table"}, the female participants in the Italian study by [@b73] and [@b74]) might be assumed to have a higher risk of NHL than the men based upon the non significant odds ratios (OR = 1.5 vs. OR = 0.7). Further, the risk when not using protective equipment (OR = 4.4), attained statistical significance and was highlighted in the publication abstract. However, the estimates were imprecise as shown by their wide confidence intervals and large confidence interval ratios. The risk estimates may be subject to chance variation. The non significant estimate of 0.9 for the overall group is the most precise, and should be considered the most trustworthy with the least random error. Thus, precision is an important consideration along with replication and statistical significance when reviewing epidemiology study results.

###### 

Comparison of results in an epidemiology study.

  Group                          OR    95% CI     Statistically significant   CI ratio
  ------------------------------ ----- ---------- --------------------------- --------------------
  Men                            0.7   0.3--1.9   No                          6.3
  Women                          1.5   0.4-5.7    No                          14.3
  Overall                        0.9   0.5-1.8    No                          3.6--most precise
  Lack of protective equipment   4.4   1.1-29.1   Yes                         26.0--least stable

From [@b73], [@b74].

In discussing specific health results, it is also important to take into account concepts related to reducing both random error and exposure misclassification. Investigators endeavor to maximize both sample size and exposure potential in selected populations. However, it is difficult to do one without sacrifcing the other. The very large AHS enrolled approximately 90 000 farmer applicators and their spouses but relied upon questionnaire based exposure determination. Urinary biomonitoring of a few AHS participants confirmed that internal doses of 2,4-D were well below exposure guidance values and that exposure was not uniform across applicators ([@b12]; [@b101]). Conversely, the occupational cohort studies of manufacturing workers of phenoxy herbicides have potentially higher and more frequent exposure but the sample sizes tend to be small. Much has been written about the problems and direction of exposure misclassification. In short, if unexposed participants are categorized as exposed, the risk estimates can be higher or lower ([@b100]; Jurek et al., 2008). Keeping these strengths and weaknesses in mind, we looked for replication from one study to another with the view that no single epidemiology study can confirm or refute a putative association.

Conclusion
==========

Our interpretation of the epidemiology literature is that there is no convincing evidence for any chronic adverse effect of 2,4-D in humans. However, the epidemiology data are only a small portion of the information available. There is an abundance of information from the biomonitoring literature. These data inform us that persons with direct contact with 2,4-D have the highest exposure and that most non-agricultural populations have little to no measurable exposure. Guided by biomonitoring we can better control exposure and target populations that are the most exposed for future health research.
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